Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...
DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep vein ...
Deep vein thrombosis (DVT) is a blood clot that forms inside a vein deep in the body, whereas superficial thrombophlebitis (STP) is inflammation of the veins just below the skin’s surface. STP can ...
Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...
The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...
A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors. A subsegmental ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results